Skip to main content
. 2019 Jun 27;14(6):e0219180. doi: 10.1371/journal.pone.0219180

Fig 5. The known PI3K/mTOR inhibitors with the highlighted portions in light yellow.

Fig 5

The nine highlighted portions are selected as R1 substituent groups from the known eight inhibitors.